113 related articles for article (PubMed ID: 20141445)
1. Telbivudine use in a patient affected by occult hepatitis B virus and B-cell non-Hodgkin lymphoma.
Montineri A; Nigro L; Chiarenza A; Larocca L; La Rosa R; Iacobello C; Di Raimondo F; Fatuzzo F
Leuk Lymphoma; 2010 Mar; 51(3):554-7. PubMed ID: 20141445
[No Abstract] [Full Text] [Related]
2. [Icteric hepatitis in a patient with non-Hodgkin's lymphoma treated by rituximab-based chemotherapy].
Coppola N; Masiello A; Tonziello G; Macera M; Iodice V; Caprio N; Pasquale G
Infez Med; 2010 Jun; 18(2):127-31. PubMed ID: 20610938
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of seropositive occult hepatitis B viral infection in lymphoma patients receiving chemotherapy.
Cheung WI; Lin SY; Leung VK; Fung KS; Lam YK; Lo FH; Chau TN
Hong Kong Med J; 2011 Oct; 17(5):376-80. PubMed ID: 21979474
[TBL] [Abstract][Full Text] [Related]
4. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
Yamagata M; Murohisa T; Tsuchida K; Okamoto Y; Tsunoda S; Nakamura M; Kusano K; Majima Y; Kuniyoshi T; Iijima M; Sugaya H; Hiraishi H
Leuk Lymphoma; 2007 Feb; 48(2):431-3. PubMed ID: 17325912
[No Abstract] [Full Text] [Related]
5. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
Law JK; Ho JK; Hoskins PJ; Erb SR; Steinbrecher UP; Yoshida EM
Leuk Lymphoma; 2005 Jul; 46(7):1085-9. PubMed ID: 16019563
[TBL] [Abstract][Full Text] [Related]
6. [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
Mimura N; Tsujimura H; Ise M; Sakai C; Kojima H; Fukai K; Yokosuka O; Takagi T; Kumagai K
Rinsho Ketsueki; 2009 Dec; 50(12):1715-9. PubMed ID: 20068280
[TBL] [Abstract][Full Text] [Related]
7. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
[TBL] [Abstract][Full Text] [Related]
8. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
[TBL] [Abstract][Full Text] [Related]
9. Telbivudine/Torcitabine Idenix/Novartis.
Hodge RA
Curr Opin Investig Drugs; 2004 Feb; 5(2):232-41. PubMed ID: 15043399
[TBL] [Abstract][Full Text] [Related]
10. [B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody].
Ishihara T; Kanagawa M; Koyama J; Hasegawa K; Suzuki T; Hirayama Y; Terui T
Rinsho Ketsueki; 2014 Nov; 55(11):2283-7. PubMed ID: 25501408
[TBL] [Abstract][Full Text] [Related]
11. [Case of obstructive jaundice as initial manifestation of non Hodgkin lymphoma in patient followed as chronic hepatitis C].
Hidaka S; Takechi S; Nonaka S; Joko K
Nihon Shokakibyo Gakkai Zasshi; 2004 Aug; 101(8):895-9. PubMed ID: 15382709
[No Abstract] [Full Text] [Related]
12. [A case of drug-induced liver injury caused by entecavir for treatment of hepatitis B virus reactivation during RCHOP in a patient with non-Hodgkin lymphoma].
Kondo M; Kitada N; Kobayashi M; Morita S; Yoshioka M; Tsuji T; Mori A; Okamoto T; Watari M
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1199-201. PubMed ID: 19620818
[TBL] [Abstract][Full Text] [Related]
13. Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.
Li X; Lin Q; Dong M; Wen JY; Wei L; Ma XK; Chen ZH; Wu XY
Leuk Lymphoma; 2010 Sep; 51(9):1678-85. PubMed ID: 20807095
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B: a "GLOBAL" health challenge.
Fontana RJ
Gastroenterology; 2009 Feb; 136(2):389-92. PubMed ID: 19109963
[No Abstract] [Full Text] [Related]
15. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
[TBL] [Abstract][Full Text] [Related]
16. Telbivudine: an upcoming agent for chronic hepatitis B.
Yuen MF; Lai CL
Expert Rev Anti Infect Ther; 2005 Aug; 3(4):489-94. PubMed ID: 16107194
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
Tsurumi H; Hara T; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Kasahara S; Goto H; Fukuno K; Yamada T; Sawada M; Shimizu M; Takahashi T; Takami T; Moriwaki H
Leuk Lymphoma; 2012 Feb; 53(2):247-53. PubMed ID: 21827339
[TBL] [Abstract][Full Text] [Related]
18. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.
Decker M; Rothermundt C; Holländer G; Tichelli A; Rochlitz C
Lancet Oncol; 2006 Aug; 7(8):693-4. PubMed ID: 16887487
[No Abstract] [Full Text] [Related]
19. Three cases of Pneumocystis jirovecii pneumonia (PCP) during first-line treatment with rituximab in combination with CHOP-14 for aggressive B-cell non-Hodgkin's lymphoma.
Venhuizen AC; Hustinx WN; van Houte AJ; Veth G; van der Griend R
Eur J Haematol; 2008 Mar; 80(3):275-6. PubMed ID: 18005387
[No Abstract] [Full Text] [Related]
20. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
